A cancer doctor speaks out: How premature hype about experimental drugs fails patients
TIME’s ‘miracle cure’ coverage reflects common problems with cancer stories
CAR T-cell therapy — Why it’s too soon to speculate about a ‘cure’ for multiple myeloma
6 things to keep in mind if you read cancer-related news in the next few days
Cancer immunotherapy: more reason for concern?
Too many stories ignore or under-report the harms of cancer immunotherapies. Here’s what the public needs to know.
At Seattle TV stations, health “news” increasingly consists of PR for area hospitals
Six tips for writing accurately about cancer immunotherapy drugs
Where are the TV ads to “educate” patients about the negative Opdivo lung cancer trial?
Five Star Friday: Vox, WSJ, NPR, USA Today, NY Times earn kudos